New study seeks to unlock immune secrets behind deadly fungal infections in ICU patients

NCT ID NCT07130799

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how the immune system responds in critically ill patients with severe abdominal infections. Researchers want to understand why some patients develop a serious fungal infection while others do not. They will measure a specific immune marker (HLA-DR) in 100 adults after emergency abdominal surgery. The goal is to improve early detection and risk assessment for fungal infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

candidemia candidiasis, invasive Critical Illness disseminated candidiasis infectious peritonitis Intraabdominal Infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU de NANCY

    RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••